Clinical and genetic heterogeneity in hereditary spastic paraplegias: From SPG1 to SPG72 and still counting
- 1 June 2015
- journal article
- review article
- Published by Elsevier BV in Revue Neurologique
- Vol. 171 (6-7), 505-530
- https://doi.org/10.1016/j.neurol.2015.02.017
Abstract
No abstract availableKeywords
Funding Information
- ANR
- European Union
- E-Rare program
- Investissements d’Avenir (ANR-10-IAIHU-06 (IHU-A-ICM))
This publication has 170 references indexed in Scilit:
- KIF1A, an Axonal Transporter of Synaptic Vesicles, Is Mutated in Hereditary Sensory and Autonomic Neuropathy Type 2American Journal of Human Genetics, 2011
- A nullimorphic ERLIN2 mutation defines a complicated hereditary spastic paraplegia locus (SPG18)neurogenetics, 2011
- Adaptor Protein Complex 4 Deficiency Causes Severe Autosomal-Recessive Intellectual Disability, Progressive Spastic Paraplegia, Shy Character, and Short StatureAmerican Journal of Human Genetics, 2011
- Excess of De Novo Deleterious Mutations in Genes Associated with Glutamatergic Systems in Nonsyndromic Intellectual DisabilityAmerican Journal of Human Genetics, 2011
- Targeted High-Throughput Sequencing Identifies Mutations in atlastin-1 as a Cause of Hereditary Sensory Neuropathy Type IAmerican Journal of Human Genetics, 2011
- Dosage-Dependent Severity of the Phenotype in Patients with Mental Retardation Due to a Recurrent Copy-Number Gain at Xq28 Mediated by an Unusual RecombinationAmerican Journal of Human Genetics, 2009
- Mutation in the AP4M1 Gene Provides a Model for Neuroaxonal Injury in Cerebral PalsyAmerican Journal of Human Genetics, 2009
- Neuropathy Target Esterase Gene Mutations Cause Motor Neuron DiseaseAmerican Journal of Human Genetics, 2008
- Sequence Alterations within CYP7B1 Implicate Defective Cholesterol Homeostasis in Motor-Neuron DegenerationAmerican Journal of Human Genetics, 2008
- Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia— Report of 19 casesMovement Disorders, 2008